Some of the recalled albuterol sulfate inhalers stop working after several uses
TUESDAY, Sept. 22, 2020 (HealthDay News) — Perrigo inhalers have been recalled because they could clog and not provide patients with any or enough medication, the U.S. Food and Drug Administration says.
The retail recall is for all unexpired albuterol sulfate inhalation aerosol made by Catalent Pharma Solutions for Perrigo Pharmaceutical Company. The inhalers are used to treat asthma and other airway/lung conditions, such as chronic obstructive pulmonary disease. Patients should continue to use the Perrigo inhaler they have, as needed and as directed by a doctor, the FDA said.
Some of the recalled inhalers stop working after several uses. If their rescue albuterol inhaler malfunctions and does not relieve symptoms in an emergency situation, patients should immediately seek emergency care if needed, the FDA advised.
The agency recommends that patients have extra inhalers or an alternative treatment available in case of inhaler malfunction.
Use of SAMA, SABA Linked to Cardiovascular Events, Mortality in Asthma, COPD 
Higher Short-Term Exposure to Pollen Linked to Lower FEV1 in COPD 
Insurance Poses Barrier to Virtual Pulmonary Rehabilitation for COPD 
Emergency Diagnosis Linked to Worse Outcomes for Range of Conditions 
Family History of CRC Increases CRC Risk Similarly in IBD, General Population 
ED Visits for Gambling Disorder Spike After Canada Liberalizes Online Gambling 
Nearly 2 in 3 Poison Exposures in Young Children May Not Need the ED 
About 1 in 20 Hospitalized U.S. Adults With Firearm Injuries Develop Bacterial Infections 
